OpGen Inc. Files 8-K with Material Agreement Details

Ticker: CFOR · Form: 8-K · Filed: Oct 9, 2024 · CIK: 1293818

Opgen Inc 8-K Filing Summary
FieldDetail
CompanyOpgen Inc (CFOR)
Form Type8-K
Filed DateOct 9, 2024
Risk Levelmedium
Pages2
Reading Time3 min
Key Dollar Amounts$0.01, $3.0 million, $9.0 million
Sentimentneutral

Sentiment: neutral

Topics: material-agreement, equity-sale, filing

TL;DR

OpGen filed an 8-K on Oct 3rd, reporting a material agreement and equity sales. Details pending.

AI Summary

On October 3, 2024, OpGen, Inc. entered into a material definitive agreement. The company also reported on unregistered sales of equity securities and filed financial statements and exhibits. The specific details of the agreement and the financial information were not fully disclosed in the provided text.

Why It Matters

This filing indicates significant corporate activity, potentially involving new agreements or financial changes that could impact OpGen's business operations and stock performance.

Risk Assessment

Risk Level: medium — The filing mentions a material definitive agreement and unregistered sales of equity, which can introduce financial and operational risks if not managed properly.

Key Players & Entities

  • OpGen, Inc. (company) — Registrant
  • October 3, 2024 (date) — Date of earliest event reported
  • Delaware (jurisdiction) — State of incorporation
  • 001-37367 (identifier) — Commission File Number
  • 06-1614015 (identifier) — I.R.S. Employer Identification Number
  • 23219 Stringtown Road , Suite 300 Clarksburg , MD 20871 (address) — Address of principal executive offices
  • (240) 813-1260 (phone_number) — Registrant's telephone number

FAQ

What is the nature of the material definitive agreement entered into by OpGen, Inc. on October 3, 2024?

The provided text states that OpGen, Inc. entered into a 'Material Definitive Agreement' on October 3, 2024, but the specific details of this agreement are not disclosed in the excerpt.

What type of equity securities were sold by OpGen, Inc. on an unregistered basis?

The filing mentions 'Unregistered Sales of Equity Securities' by OpGen, Inc., but the specific type and amount of securities are not detailed in the provided text.

What are the key financial statements and exhibits filed by OpGen, Inc. with this 8-K?

The filing indicates that 'Financial Statements and Exhibits' were included, but the content of these documents is not specified in the excerpt.

Where is OpGen, Inc.'s principal executive office located?

OpGen, Inc.'s principal executive offices are located at 23219 Stringtown Road, Suite 300, Clarksburg, MD 20871.

What is OpGen, Inc.'s telephone number?

OpGen, Inc.'s telephone number, including area code, is (240) 813-1260.

Filing Stats: 704 words · 3 min read · ~2 pages · Grade level 11.5 · Accepted 2024-10-09 16:15:19

Key Financial Figures

  • $0.01 — 2024, shares of common stock, par value $0.01 per share (the "Shares"), of the Compan
  • $3.0 million — pany having an aggregate value of up to $3.0 million (the "Financing"). On October 3, 2024,
  • $9.0 million — illion each, for an aggregate amount of $9.0 million under the Purchase Agreement; and (2) e

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: October 9, 2024 OpGen, Inc. By: /s/ John Tan Honjian Name: John Tan Honjian Title: Chairman and Chief Executive Officer 2

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.